Halozyme Therapeutics, Inc. (HALO)
70.98
+0.34
(+0.48%)
USD |
NASDAQ |
Feb 24, 14:10
Halozyme Therapeutics EPS Diluted (TTM) : 2.492 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Johnson & Johnson | 11.05 |
| Merck & Co., Inc. | 7.275 |
| Skye Bioscience, Inc. | -1.290 |
| AIM ImmunoTech, Inc. | -14.93 |
| Stryker Corp. | 8.398 |